share_log
Reuters ·  May 3 07:12
Mhra: Has Authorised Cabotegravir as 30 Mg Tablets and as a 600 Mg Long-Acting Injection Administered Every Two Months
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment